NL192201C - Farmacologisch actieve fenylaminoalkylcyclobutaanverbindingen en preparaten die deze verbindingen bevatten. - Google Patents

Farmacologisch actieve fenylaminoalkylcyclobutaanverbindingen en preparaten die deze verbindingen bevatten. Download PDF

Info

Publication number
NL192201C
NL192201C NL8201347A NL8201347A NL192201C NL 192201 C NL192201 C NL 192201C NL 8201347 A NL8201347 A NL 8201347A NL 8201347 A NL8201347 A NL 8201347A NL 192201 C NL192201 C NL 192201C
Authority
NL
Netherlands
Prior art keywords
formula
ether
mixture
group
cyclobutyl
Prior art date
Application number
NL8201347A
Other languages
English (en)
Dutch (nl)
Other versions
NL8201347A (nl
NL192201B (nl
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26279045&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL192201(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Knoll Ag filed Critical Knoll Ag
Publication of NL8201347A publication Critical patent/NL8201347A/nl
Publication of NL192201B publication Critical patent/NL192201B/xx
Application granted granted Critical
Publication of NL192201C publication Critical patent/NL192201C/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
    • C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
    • C07C29/147—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/40—Halogenated unsaturated alcohols
    • C07C33/50—Halogenated unsaturated alcohols containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/004—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reaction with organometalhalides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/42—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by hydrolysis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/44—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reduction and hydrolysis of nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/227—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing halogen
    • C07C49/237—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings and other rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/527—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings
    • C07C49/567—Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/46—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms containing six-membered aromatic rings and other rings, e.g. cyclohexylphenylacetic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/16—Unsaturated compounds
    • C07C61/40—Unsaturated compounds containing halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Psychiatry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
NL8201347A 1981-04-06 1982-03-31 Farmacologisch actieve fenylaminoalkylcyclobutaanverbindingen en preparaten die deze verbindingen bevatten. NL192201C (nl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8110709 1981-04-06
GB8110710 1981-04-06
GB8110710 1981-04-06
GB8110709 1981-04-06

Publications (3)

Publication Number Publication Date
NL8201347A NL8201347A (nl) 1982-11-01
NL192201B NL192201B (nl) 1996-11-01
NL192201C true NL192201C (nl) 1997-03-04

Family

ID=26279045

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8201347A NL192201C (nl) 1981-04-06 1982-03-31 Farmacologisch actieve fenylaminoalkylcyclobutaanverbindingen en preparaten die deze verbindingen bevatten.

Country Status (40)

Country Link
KR (1) KR900000274B1 (es)
AT (1) AT382612B (es)
AU (1) AU545595B2 (es)
BG (2) BG40652A3 (es)
CA (1) CA1248955A (es)
CH (1) CH652117A5 (es)
CS (1) CS244672B2 (es)
CY (1) CY1408A (es)
DD (1) DD208348A5 (es)
DE (1) DE3212682A1 (es)
DK (1) DK161770C (es)
ES (5) ES8305678A1 (es)
FI (1) FI77223C (es)
FR (1) FR2504920B1 (es)
GB (1) GB2098602B (es)
GE (1) GEP19970661B (es)
GR (1) GR76697B (es)
HK (1) HK13888A (es)
HU (1) HU186582B (es)
IE (1) IE52768B1 (es)
IL (1) IL65257A0 (es)
IN (1) IN155773B (es)
IT (1) IT1235758B (es)
JO (1) JO1184B1 (es)
KE (1) KE3753A (es)
LU (1) LU84070A1 (es)
MY (1) MY8800048A (es)
NL (1) NL192201C (es)
NO (1) NO156785C (es)
NZ (1) NZ200178A (es)
PH (1) PH22762A (es)
PL (2) PL139120B1 (es)
PT (1) PT74580B (es)
RO (2) RO84802B (es)
SE (1) SE452611B (es)
SG (1) SG67287G (es)
SU (2) SU1482522A3 (es)
UA (2) UA7589A1 (es)
YU (2) YU44336B (es)
ZW (1) ZW4982A1 (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE56000B1 (en) * 1982-09-30 1991-03-13 Boots Co Plc 1-arylcyclobutylalkylamine compounds
IE56001B1 (en) * 1982-09-30 1991-03-13 Boots Co Plc 1-arylcyclobutylmethylamine compounds
GB8412480D0 (en) * 1984-05-16 1984-06-20 Elliott M Pesticides
DK58285D0 (da) * 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
GB8501192D0 (en) * 1985-01-17 1985-02-20 Boots Co Plc Therapeutic agents
US5157021A (en) * 1985-03-15 1992-10-20 Novo Nordisk A/S Insulin derivatives and pharmaceutical preparations containing these derivatives
DK119785D0 (da) * 1985-03-15 1985-03-15 Nordisk Gentofte Insulinpraeparat
GB2184122B (en) * 1985-12-17 1989-10-18 Boots Co Plc N,n-dimethyl-1-[1-(4-chlorophenyl)cyclobutyl]-3-methyl butylamine hydrochloride monohydrate
GB8531071D0 (en) * 1985-12-17 1986-01-29 Boots Co Plc Therapeutic compound
GB8704777D0 (en) * 1987-02-28 1987-04-01 Boots Co Plc Medical treatment
JP2675573B2 (ja) * 1988-03-31 1997-11-12 科研製薬株式会社 脳機能改善剤
WO1994000114A1 (en) * 1992-06-23 1994-01-06 Sepracor Inc. Methods and compositions for treating depression and other disorders using optically pure (-) sibutramine
GB9309749D0 (en) * 1993-05-12 1993-06-23 Boots Co Plc Therapeutic agents
US5459164A (en) * 1994-02-03 1995-10-17 Boots Pharmaceuticals, Inc. Medical treatment
DE19518988A1 (de) * 1995-05-29 1996-12-05 Basf Ag Verwendung arylsubstituierter Cyclobutylalkylamine zur Behandlung der Fettleibigkeit
GB9524681D0 (en) 1995-12-02 1996-01-31 Knoll Ag Chemical process
GB9619757D0 (en) 1996-09-21 1996-11-06 Knoll Ag Chemical process
GB9619962D0 (en) * 1996-09-25 1996-11-13 Knoll Ag Medical treatment
GB9619961D0 (en) * 1996-09-25 1996-11-13 Knoll Ag Medical treatment
GB9727131D0 (en) 1997-12-24 1998-02-25 Knoll Ag Therapeutic agents
US6476078B2 (en) 1999-08-11 2002-11-05 Sepracor, Inc. Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
US6339106B1 (en) 1999-08-11 2002-01-15 Sepracor, Inc. Methods and compositions for the treatment and prevention of sexual dysfunction
AU2007200334B8 (en) * 1998-08-24 2010-10-21 Sepracor, Inc. Methods of using and compositions comprising dopamine reuptake inhibitors
US6974838B2 (en) 1998-08-24 2005-12-13 Sepracor Inc. Methods of treating or preventing pain using sibutramine metabolites
US6331571B1 (en) * 1998-08-24 2001-12-18 Sepracor, Inc. Methods of treating and preventing attention deficit disorders
BG65170B1 (bg) * 1999-03-17 2007-05-31 Knoll Gmbh Използване на n-заместени производни на 1-[1-(4-хлорофенил)циклобутил]-3-метилбутиламин за производство на лекарство за лечение на разстройства при храненето
US6552087B1 (en) 1999-03-19 2003-04-22 Abbott Gmbh & Co. Kg Therapeutic agent comprising (+)-sibutramine
GB9915617D0 (en) 1999-07-05 1999-09-01 Knoll Ag Therapeutic agents
US6399826B1 (en) * 1999-08-11 2002-06-04 Sepracor Inc. Salts of sibutramine metabolites, methods of making sibutramine metabolites and intermediates useful in the same, and methods of treating pain
AU2002210816A1 (en) * 2000-11-02 2002-05-15 Torrent Pharmaceuticals Ltd Process for preparation of beta-phenethylamine derivative
WO2002083631A1 (en) 2001-04-13 2002-10-24 Sepracor Inc. Methods of preparing didesmethylsibutramine and other sibutramine derivatives
KR100536750B1 (ko) * 2002-10-05 2005-12-16 한미약품 주식회사 시부트라민 메탄술폰산염의 결정성 반수화물을 포함하는약학 조성물
FR2870537A1 (fr) * 2004-05-19 2005-11-25 Servier Lab Nouveau procede de synthese du (1s)-4,5-dimethoxy-1-(methyl aminomethyl-)-benzocyclobutane et de ses sels d'addition, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
KR100606533B1 (ko) 2004-08-27 2006-08-01 한올제약주식회사 시부트라민의 개선된 합성방법
KR100606534B1 (ko) 2004-11-01 2006-08-01 한올제약주식회사 생산성을 향상시킨 시부트라민의 개선된 합성방법
KR100618176B1 (ko) * 2004-12-02 2006-09-01 휴먼팜 주식회사 시부트라민 주석산염, 이의 제조 방법 및 이를 포함하는약학적 조성물
US7432398B2 (en) 2005-01-06 2008-10-07 Cj Corporation Inorganic acid salts of sibutramine
US8604244B2 (en) 2010-07-02 2013-12-10 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using cycloalkylmethylamine derivatives
EP2066329B1 (en) * 2006-09-15 2017-09-06 Reviva Pharmaceuticals, Inc. Synthesis, methods of using, and compositions of cyclobutylmethylamines
CN101555214B (zh) * 2008-04-08 2012-07-11 北京嘉事联博医药科技有限公司 苯基环丁基酰胺衍生物及其光学异构体、制备方法和用途
FR2935381B1 (fr) * 2008-08-29 2010-12-17 Servier Lab Nouveau procede de resolution des enantiomerees du (3,4-dimethoxy-bicyclo°4.2.0!octa-1,3,5-trien-7-yl)nitrile et application a la synthese de l'ivabradine
WO2010082216A2 (en) * 2008-12-08 2010-07-22 Matrix Laboratories Ltd Novel salts of sibutramine and their crystal forms
JP5696156B2 (ja) 2009-11-02 2015-04-08 ファイザー・インク ジオキサ−ビシクロ［３．２．１］オクタン−２，３，４−トリオール誘導体
US9238625B2 (en) * 2011-12-30 2016-01-19 Reviva Pharmaceuticals, Inc. Compositions, synthesis, and methods of using phenylcycloalkylmethylamine derivatives
FR2993561B1 (fr) * 2012-07-17 2014-10-31 Servier Lab Procede de synthese enzymatique de la (7s)-1-(3,4-dimethoxy bicyclo[4.2.0]octa-1,3,5-triene 7-yl) n-methyl methanamine, et application a la synthese de l'ivabradine et de ses sels

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1124485B (de) * 1960-02-12 1962-03-01 Hoechst Ag Verfahren zur Herstellung von analeptisch wirksamen Phenylcycloalkylmethylaminen
US3526656A (en) * 1967-05-25 1970-09-01 Parke Davis & Co (1-arylcyclobutyl)carbonyl carbamic acid derivatives

Also Published As

Publication number Publication date
NL8201347A (nl) 1982-11-01
RO84802B (ro) 1984-10-30
DD208348A5 (de) 1984-05-02
ES519029A0 (es) 1984-08-01
NO821087L (no) 1982-10-07
YU6385A (en) 1985-08-31
DK146482A (da) 1982-10-07
FR2504920B1 (fr) 1985-06-28
ES519030A0 (es) 1984-08-01
HK13888A (en) 1988-02-26
GB2098602A (en) 1982-11-24
HU186582B (en) 1985-08-28
BG40652A3 (en) 1986-01-15
SU1461372A3 (ru) 1989-02-23
IT8248157A0 (it) 1982-04-02
IT1235758B (it) 1992-09-28
NO156785B (no) 1987-08-17
IE52768B1 (en) 1988-02-17
CS245782A2 (en) 1985-08-15
CH652117A5 (fr) 1985-10-31
FI77223B (fi) 1988-10-31
CS244672B2 (en) 1986-08-14
PL235832A1 (en) 1983-09-12
GB2098602B (en) 1984-08-22
ES511152A0 (es) 1983-04-16
ES8407002A1 (es) 1984-08-16
ES519032A0 (es) 1984-03-01
ZW4982A1 (en) 1982-11-03
NO156785C (no) 1987-11-25
MY8800048A (en) 1988-12-31
PL136242B1 (en) 1986-02-28
DE3212682C2 (es) 1992-03-26
FI821197A0 (fi) 1982-04-05
GR76697B (es) 1984-08-28
YU44253B (en) 1990-04-30
CY1408A (en) 1988-04-22
UA7838A1 (uk) 1995-12-26
IL65257A0 (en) 1983-12-30
FI77223C (fi) 1989-02-10
IN155773B (es) 1985-03-09
LU84070A1 (fr) 1983-06-07
KE3753A (en) 1987-10-02
DE3212682A1 (de) 1982-10-21
ES8406413A1 (es) 1984-08-01
NZ200178A (en) 1985-07-31
NL192201B (nl) 1996-11-01
ATA132582A (de) 1986-08-15
FI821197L (fi) 1982-10-07
YU75082A (en) 1985-08-31
AU545595B2 (en) 1985-07-18
PT74580B (en) 1983-12-23
PL240079A1 (en) 1983-09-12
SE452611B (sv) 1987-12-07
DK161770C (da) 1992-02-10
IE820481L (en) 1982-10-06
AU8221382A (en) 1982-10-14
UA7589A1 (uk) 1995-09-29
ES519031A0 (es) 1984-08-16
BG40651A3 (en) 1986-01-15
PL139120B1 (en) 1986-12-31
YU44336B (en) 1990-06-30
RO84802A (ro) 1984-09-29
AT382612B (de) 1987-03-25
DK161770B (da) 1991-08-12
JO1184B1 (en) 1983-11-30
GEP19970661B (en) 1997-01-04
SG67287G (en) 1988-02-19
ES8406414A1 (es) 1984-08-01
FR2504920A1 (fr) 1982-11-05
PH22762A (en) 1988-12-12
KR900000274B1 (ko) 1990-01-24
KR830010065A (ko) 1983-12-26
ES8305678A1 (es) 1983-04-16
SE8202166L (sv) 1982-11-25
CA1248955A (en) 1989-01-17
RO89436A2 (ro) 1986-06-30
ES8403097A1 (es) 1984-03-01
PT74580A (en) 1982-04-01
SU1482522A3 (ru) 1989-05-23

Similar Documents

Publication Publication Date Title
NL192201C (nl) Farmacologisch actieve fenylaminoalkylcyclobutaanverbindingen en preparaten die deze verbindingen bevatten.
US4522828A (en) Therapeutic agents
AU2007205114B2 (en) Cycloalkylamines as monoamine reuptake inhibitors
DE19525137A1 (de) 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbindungen als pharmazeutische Wirkstoffe
US4443449A (en) Arylcyclobutylalkylamines and anti-depression composition and methods using same
JP2017526690A (ja) Ｎ−アルキルポリアミンの製造方法
DE10235312A1 (de) Verfahren zur Herstellung von Aminoalkoxybenzylaminen und Aminoalkoxybenzonitrilen als Zwischenprodukte
DE60107292T2 (de) Verfahren zur Herstellung von (+)-trans-4-p-Fluorophenyl-3-hydroxymethyl-1-methylpiperidin
Burger et al. Amino Derivatives of 2, 2-Diphenylcyclohexanone. I1
SU786885A3 (ru) Способ получени производных бензиламина
US3555093A (en) 2,alpha-dimenthyl-beta-ethyl-beta-(p-fluorophenyl)-ethylamines and the salts thereof
DE60111349T2 (de) Verfahren zur Herstellung von 1-(2-Dimethylamino-(4-methoxyphenyl)-ethyl)cyclohexanol
Zuech et al. The Synthesis of Aldehydes from the Reaction of Amines with Butadiene
Wada et al. The Reaction of Enamines with N-Dialkylchloramines
CS215118B2 (en) Method of making the cis-bicyclooktylamines
JPS62226949A (ja) 含窒素ノルボルネン誘導体
DE19545875A1 (de) Verfahren zur Herstellung von Aminen aus Olefinen an Zeolithen des Typs SSZ-26, SSZ-33, CIT-1 oder deren Gemischen
MX2008008807A (es) Cicloalquilaminas como inhibidores de la recaptacion de monoaminas
JPS63310854A (ja) １−アルコキシフェニル−２−アミノ−１−アルコ−ル類の製造方法
HU202478B (en) Process for producing cis- and trans-2-(aminomethyl)-cycloalkanols
DE1143511B (de) Verfahren zur Herstellung neuer Cyclohexanderivate
DE1048592B (es)

Legal Events

Date Code Title Description
A1A A request for search or an international-type search has been filed
AK Correction of former applications already laid open

Free format text: P.BUL.21/82,HEADING A,SEC 1,2,3: "A" AFTER THIS SPECIFICATION SHOULD BE DELETED

DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: BOOTS COMPANY PLC. THE -

A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: KNOLL AG

V4 Discontinued because of reaching the maximum lifetime of a patent

Free format text: 20020331

V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20020331